Home
Small Molecules: Hit identification
Small Molecules: Hit-to-Lead optimization
Small Molecules: physicochemical properties
Small Molecules: ADME
Small Molecules: Toxicity
Small Molecules: Selectivity
Antibodies: Humanization and Optimization
Protein Modeling. Discovery
Protein Modeling: HERG binding
Protein Modeling: Albumin binding
- Quantum Discussions Forum
You access the old version of our website. Please point your browser to our new home page.
Investors
Quantum Pharmaceuticals raised its first round of venture financing in 2003. In order to build an industry-leading company, we are looking additional funding through venture capital. We treat our investors as long-term business partners, combining excellent business judgment and proactive leadership to help us succeed.
Quantum Pharmaceuticals has all the ingredients necessary for success:
1. Enormous market opportunity: Advances in genomics and the mapping of the
human genome have resulted in an enormous increase in the number of potential
disease-targets, which, in turn, has increased the demand for advanced drug
discovery technologies.
2. Revolutionary technology: Our technology is able to rapidly identify and optimize novel drug-like molecules for a given target by using quantum physics and sophisticated artificial intelligence methods. Quantum Pharmaceuticals' technology combines the best features of real and virtual techniques to reduce failure rates dramatically, increase time-effectiveness, and reduce the cost of drug discovery.
3. A-quality team: Our company has assembled an experienced international team of professionals with specialties ranging from theoretical physics and computer science to finance and marketing. Our team is able to deliver results and is prepared to work on a 24/7 schedule until we reach our goal.
Quantum Pharmaceuticals’ business development strategy includes a number of programs of drug discovery and technological development. If you are interested in receiving more information on these, please, contact us.